Ryan T. Cirz

1.9k total citations
18 papers, 1.3k citations indexed

About

Ryan T. Cirz is a scholar working on Molecular Biology, Molecular Medicine and Genetics. According to data from OpenAlex, Ryan T. Cirz has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Molecular Medicine and 8 papers in Genetics. Recurrent topics in Ryan T. Cirz's work include Antibiotic Resistance in Bacteria (10 papers), Bacterial Genetics and Biotechnology (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Ryan T. Cirz is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Bacterial Genetics and Biotechnology (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Ryan T. Cirz collaborates with scholars based in United States and United Kingdom. Ryan T. Cirz's co-authors include Floyd E. Romesberg, Jodie K. Chin, Valérie de Crécy‐Lagard, David R. Andes, William A. Craig, Bryan M. O’Neill, Steven R. Head, Jennifer Hammond, Neill A. Gingles and Marcus B. Jones and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Ryan T. Cirz

18 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ryan T. Cirz

Since Specialization

Citations

This map shows the geographic impact of Ryan T. Cirz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan T. Cirz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan T. Cirz more than expected).

Fields of papers citing papers by Ryan T. Cirz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan T. Cirz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan T. Cirz. The network helps show where Ryan T. Cirz may publish in the future.

Co-authorship network of co-authors of Ryan T. Cirz

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan T. Cirz. A scholar is included among the top collaborators of Ryan T. Cirz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan T. Cirz. Ryan T. Cirz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020 2022 ·Antimicrobial Agents and Chemotherapy ·Neha Prasad, Ian B. Seiple, Ryan T. Cirz, Oren S. Rosenberg	67
2	Small-molecule sensitization of RecBCD helicase–nuclease to a Chi hotspot-activated state 2020 ·Nucleic Acids Research ·(unknown), Ryan T. Cirz, Andrew F. Taylor, Gerald R. Smith	6
3	Unraveling the Gentamicin Drug Product Complexity Reveals Variation in Microbiological Activities and Nephrotoxicity 2020 ·Antimicrobial Agents and Chemotherapy ·Zackery P. Bulman, Ryan T. Cirz, Darin J. Hildebrandt, Tim Kane, (unknown), (unknown), (unknown), Logan D. Andrews	13
4	Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase 2019 ·Journal of Medicinal Chemistry ·Logan D. Andrews, Timothy R. Kane, Paola Dozzo, Cat M. Haglund, (unknown), Martin S. Linsell, Timothy Machajewski, (unknown), Alisa W. Serio, Kenneth B. Wlasichuk, David B. Neau, Svetlana Pakhomova, Grover L. Waldrop, Marc D. Sharp, Joe Pogliano, Ryan T. Cirz, Frederick Cohen	26
5	Synthesis and Microbiological Evaluation of Novel Tetracyclic Fluoroquinolones 2017 ·ChemMedChem ·Allan S. Wagman, Ryan T. Cirz, Glenn McEnroe, James B. Aggen, Martin S. Linsell, (unknown), Sara López, Marcela Gómez, (unknown), (unknown), Thomas R. Belliotti, Christina R. Harris, (unknown), (unknown), R.D. Gaston, Heinz E. Moser	20
6	Plazomicin is effective in a non-human primate pneumonic plague model 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), Melanie Doyle‐Eisele, Robert Cass, Corwin F. Kostrub, Robert Sherwood, (unknown), Ryan T. Cirz	9
7	Exploring the active site of the Streptococcus pneumoniae topoisomerase IV–DNA cleavage complex with novel 7,8-bridged fluoroquinolones 2016 ·Open Biology ·Ivan Laponogov, (unknown), Dennis A. Veselkov, Ryan T. Cirz, Allan S. Wagman, Heinz E. Moser, L. Mark Fisher, Mark R. Sanderson	23
8	Natural History of Francisella tularensis in Aerosol-Challenged BALB/c Mice 2016 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, (unknown), (unknown), Ryan T. Cirz, Robert Cass, Arnold Louie, George L. Drusano	7
9	Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model 2014 ·The Journal of Infectious Diseases ·George L. Drusano, (unknown), Steven Fikes, Ryan T. Cirz, (unknown), (unknown), (unknown), D. N. Brown, Dodge L. Baluya, Arnold Louie	63
10	Telemetry used to determine efficacy of intravenous plazomicin against inhaled tularemia in cynomolgus macaques (CM) 2014 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), (unknown), Ryan T. Cirz, Robert Cass, Michelle Wright Valderas, Robert Sherwood	3
11	Natural History of Yersinia pestis Pneumonia in Aerosol-Challenged BALB/c Mice 2013 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, (unknown), (unknown), Gregory J. Hurteau, Ryan T. Cirz, Robert Cass, Arnold Louie, George L. Drusano	14
12	Controlling Mutation: Intervening in Evolution as a Therapeutic Strategy 2007 ·Critical Reviews in Biochemistry and Molecular Biology ·Ryan T. Cirz, Floyd E. Romesberg	53
13	Structural and Initial Biological Analysis of Synthetic Arylomycin A₂ 2007 ·Journal of the American Chemical Society ·Tucker C. Roberts, Peter A. Smith, Ryan T. Cirz, Floyd E. Romesberg	98
14	Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin 2006 ·Journal of Bacteriology ·Ryan T. Cirz, Marcus B. Jones, Neill A. Gingles, Timothy D. Minogue, Behnam Jarrahi, Scott N. Peterson, Floyd E. Romesberg	212
15	Side effects may include evolution 2006 ·Nature Medicine ·Ryan T. Cirz, Neill A. Gingles, Floyd E. Romesberg	10
16	Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin 2006 ·Journal of Bacteriology ·Ryan T. Cirz, Bryan M. O’Neill, Jennifer Hammond, Steven R. Head, Floyd E. Romesberg	208
17	Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance 2005 ·PLoS Biology ·Ryan T. Cirz, Jodie K. Chin, David R. Andes, Valérie de Crécy‐Lagard, William A. Craig, Floyd E. Romesberg	407
18	Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria 2005 ·Antimicrobial Agents and Chemotherapy ·Ryan T. Cirz, Floyd E. Romesberg	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact